Considering the crucial role of renal fibrosis in the development and progression of DN, as well as the influence of Hsp90 on fibrosis-related signaling pathways, we hypothesize that the accuracy of Hsp90 as a peripheral blood marker for MCI in diabetes may vary between individuals with and without DN. This evidence concerns the gene HSP90AA1 and diabetes mellitus.